Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Ischemic Heart Disease

Free Subscription 08.09.2025 1 Am Heart J 5 Am J Cardiol 1 Am J Crit Care 4 Am J Med 1 Ann Intern Med 2 Ann Thorac Surg 2 Arterioscler Thromb Vasc Biol 3 BMJ 22 Catheter Cardiovasc Interv 1 Circ Cardiovasc Imaging 1 Circ J 7 Circulation 1 Clin Cardiol 1 Clin Chem 5 Eur Heart J 1 Heart 5 Int J Cardiol 8 J Am Coll Cardiol 1 J Mol Cell Cardiol 1 J Thorac Cardiovasc Surg 4 JAMA 9 Lancet 10 N Engl J Med 4 PLoS One 1 Prog Cardiovasc Dis

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am Heart J

1. DE ROJAS JP, Toledo E, Estruch R, Guasch-Ferre M, et al
   Extra-Virgin Olive Oil and Additional Cardiovascular Outcomes in the PREDIMED Trial: An Outcome-Wide Perspective.
   Am Heart J. 2025 Sep 2:S0002-8703(25)00321-7. doi: 10.1016/j.ahj.2025.
   PubMed         Abstract available
   
   

   
   Am J Cardiol

2. JO J, Joh HS, Kim HK, Kim JH, et al
   The Clinical Impact of Intravascular Imaging-Guided Percutaneous Coronary Intervention in Acute Myocardial Infarction Patients with High Thrombus Burden.
   Am J Cardiol. 2025 Sep 2:S0002-9149(25)00537.
   PubMed         Abstract available
   
   
3. DEMIRTAKAN ZG, Tas A, Alan Y, Ozcan A, et al
   Comparison of Anatomical and Physiological Indices of Angiographically Intermediate Left Main Coronary Artery Stenoses.
   Am J Cardiol. 2025 Sep 3:S0002-9149(25)00512.
   PubMed         Abstract available
   
   
4. BCHARAH H, Bcharah G, Nabi HA, Dreher L, et al
   Extracoronary Arterial Pathologies in Patients With Spontaneous Coronary Artery Dissection (SCAD).
   Am J Cardiol. 2025 Sep 3:S0002-9149(25)00508.
   PubMed         Abstract available
   
   
5. KHARSA C, Hatab T, Chaaya RB, Qamar F, et al
   Percutaneous Coronary Intervention for Acute Coronary Syndrome in Young Adults on Dialysis: Insights from Houston Methodist Young ACS-PCI Registry.
   Am J Cardiol. 2025 Sep 1:S0002-9149(25)00507.
   PubMed         Abstract available
   
   
6. MA X, Shibata Y, Kurihara O, Kobayashi N, et al
   Identifying Pathogenesis of Acute Coronary Syndromes using Sequence Contrastive Learning in Coronary Angiography.
   Am J Cardiol. 2025 Sep 1:S0002-9149(25)00516.
   PubMed         Abstract available
   
   

   
   Am J Crit Care

7. ISSA RI, Adie SK, Marshall VD, Ketcham SW, et al
   Racial Disparities in Cardiogenic Shock Outcomes: Single-Center Retrospective Study.
   Am J Crit Care. 2025;34:385-389.
   PubMed         Abstract available
   
   

   
   Am J Med

8. KANG Y, Zhao Z, Yang Z, Zeng L, et al
   Beta-Blockers and Outcome in Patients with Suspected Coronary Artery Disease Evaluated Noninvasively.
   Am J Med. 2025;138:1257-1263.
   PubMed         Abstract available
   
   
9. KADOSH S, Balkin N, Carasso S, Amsalem I, et al
   Reduced Left Ventricular Apical Rotation: A Novel Pathophysiological Correlate Underlining Acute Ischemic Mitral Regurgitation.
   Am J Med. 2025;138:1278-1284.
   PubMed         Abstract available
   
   
10. LONNBERG F, Siddiqui AJ
    Risk of Cardiovascular Events in Patients Diagnosed with Venous Thromboembolism.
    Am J Med. 2025 Aug 29:S0002-9343(25)00560-1. doi: 10.1016/j.amjmed.2025.
    PubMed         Abstract available
    
    
11. JOLOBE OMP
    The Association of Spontaneous Coronary Artery Dissection and Myocardial Bridging.
    Am J Med. 2025;138:e191.
    PubMed        
    
    

    
    Ann Intern Med

12. FIELD TS
    In AIS due to LVO presenting within 4.5 h of onset, adding tenecteplase to EVT increased functional independence at 90 d.
    Ann Intern Med. 2025 Sep 2. doi: 10.7326/ANNALS-25-03337.
    PubMed         Abstract available
    
    

    
    Ann Thorac Surg

13. YANG C, Singh S, Ogami T, Kirilina D, et al
    Arterial Grafting Survival Benefit in End Stage Renal Disease Patients Undergoing Coronary Arterial Bypass Grafting.
    Ann Thorac Surg. 2025 Sep 2:S0003-4975(25)00841.
    PubMed         Abstract available
    
    
14. WISNIEWSKI AM, El Moheb M, Polavarapu N, Goudarzi A, et al
    Venous Thromboembolism after Coronary Artery Bypass Increases Healthcare Costs: A Propensity Score Matched Analysis.
    Ann Thorac Surg. 2025 Aug 28:S0003-4975(25)00799.
    PubMed         Abstract available
    
    

    
    Arterioscler Thromb Vasc Biol

15. SANTINELLI-PESTANA DV, Delwarde C, Kasai T, Kuraoka S, et al
    ADP-Ribosylation in Experimental Atherosclerosis: A Potential Link Between Dyslipidemia and Inflammation in Cardiovascular Disease.
    Arterioscler Thromb Vasc Biol. 2025 Sep 4. doi: 10.1161/ATVBAHA.125.322497.
    PubMed        
    
    
16. GARSHICK MS, Drenkova K, Kazatsker F, Boothman I, et al
    Platelet Activation and a Platelet Biosignature Are Associated With Cardiovascular Risk in Patients With Controlled Psoriasis.
    Arterioscler Thromb Vasc Biol. 2025 Sep 4. doi: 10.1161/ATVBAHA.125.322574.
    PubMed         Abstract available
    
    

    
    BMJ

17. ZHANG J, Liu X, Xu Y
    Cardiovascular toxicity risks in treating EGFR-mutated lung cancer.
    BMJ. 2025;390:r1834.
    PubMed        
    
    
18. MA Z, Cao F, Liao M, Min R, et al
    Cardiovascular adverse events associated with epidermal growth factor receptor tyrosine kinase inhibitors in EGFR-mutated non-small cell lung cancer: systematic review and network meta-analysis.
    BMJ. 2025;390:e082834.
    PubMed         Abstract available
    
    
19. BOWIE K
    Clopidogrel better than aspirin for preventing heart attack and stroke in patients with coronary artery disease, study finds.
    BMJ. 2025;390:r1844.
    PubMed        
    
    

    
    Catheter Cardiovasc Interv

20. FRAICHOT V, Varlot J, Eggenspieler F, Djaballah N, et al
    Coronary Ectasia and ST Elevation Myocardial Infarction Patients: Does Atherosclerosis Influence Periprocedural Management and Long-Term Prognosis?
    Catheter Cardiovasc Interv. 2025 Sep 3. doi: 10.1002/ccd.70142.
    PubMed         Abstract available
    
    
21. SUWA H, Yasumura K, Sharma SK, Kini AS, et al
    Intravascular Ultrasound-Detected Layered Plaque Mimicking Spontaneous Coronary Artery Dissection.
    Catheter Cardiovasc Interv. 2025 Jul 24. doi: 10.1002/ccd.70054.
    PubMed         Abstract available
    
    
22. STREPKOS D, Alexandrou M, Mutlu D, Carvalho PEP, et al
    Validation of the V-RESOLVE Score for Side Branch Occlusion in the PROGRESS-BIFURCATION Registry.
    Catheter Cardiovasc Interv. 2025;106:1958-1965.
    PubMed         Abstract available
    
    
23. WANG C, Chen L, Xu X
    The Predictive Value of Quantitative Flow Ratio and Its Derived Angiographic Microvascular Resistance for Restenosis Following Drug-Coated Balloon Angioplasty.
    Catheter Cardiovasc Interv. 2025 Jul 23. doi: 10.1002/ccd.70028.
    PubMed         Abstract available
    
    
24. ZHAO H, Sun Y, Fu B, Hou Y, et al
    Triglyceride-Glucose Index Is Associated With Restenosis After Percutaneous Coronary Intervention With Drug-Coated Balloons in Patients With Coronary Artery Disease.
    Catheter Cardiovasc Interv. 2025 Jul 22. doi: 10.1002/ccd.70025.
    PubMed         Abstract available
    
    
25. ISKANDER M, Anwaruddin S, Pearson P, Mason PJ, et al
    Percutaneous Transapical Bioprosthetic Leaflet Modification Facilitated Transfemoral Valve-in-Surgical Bioprosthetic Transcatheter Aortic Valve Replacement: Undermining Iatrogenic Coronary Obstruction With Radiofrequency Needle (UNICORN).
    Catheter Cardiovasc Interv. 2025 Jul 22. doi: 10.1002/ccd.70037.
    PubMed         Abstract available
    
    
26. HOWES S, Altaee O, Ramirez A, Calaquian L, et al
    Breaking the Barrier: Unraveling the No-Reflow Phenomenon in Cardiovascular Medicine.
    Catheter Cardiovasc Interv. 2025;106:1937-1945.
    PubMed         Abstract available
    
    
27. MUTLU D, Ser OS, Strepkos D, Carvalho PE, et al
    Acute Kidney Injury Requiring Dialysis Following Percutaneous Coronary Intervention: Insights From the PROGRESS-COMPLICATIONS Registry.
    Catheter Cardiovasc Interv. 2025 Jul 17. doi: 10.1002/ccd.70012.
    PubMed         Abstract available
    
    
28. O'CALLAGHAN D, Rai H, Giacoppo D, Coughlan JJ, et al
    Drug Coated Balloons Versus Drug-Eluting Stents in Patients With De Novo Coronary Artery Disease.
    Catheter Cardiovasc Interv. 2025;106:1843-1853.
    PubMed         Abstract available
    
    
29. TOUMA G, Fairley S, Ada C, Wong B, et al
    A Contemporary Framework for the Diagnosis and Management of Stent Fracture.
    Catheter Cardiovasc Interv. 2025;106:1821-1827.
    PubMed         Abstract available
    
    
30. FENG W, Liu H, Zhao J, Che J, et al
    An Anomalous LAD Originating Separately From Right Coronary Sinus: A Case Report.
    Catheter Cardiovasc Interv. 2025;106:1812-1816.
    PubMed         Abstract available
    
    
31. LEIBUNDGUT G, Achim A, Weilenmann D, Rigger J, et al
    Management of Lost Atherectomy Devices in the Coronary Arteries.
    Catheter Cardiovasc Interv. 2025;106:1766-1780.
    PubMed         Abstract available
    
    
32. WU TT, Zheng YY, Wang ZL, Pan Y, et al
    A Nearly 50% Risk of MACCE Cutdown by Personalized Antiplatelet Therapy: The Subgroup Analysis of Hypertension in PATH-PCI Trial.
    Catheter Cardiovasc Interv. 2025;106:1723-1731.
    PubMed         Abstract available
    
    
33. GALEOTE G, Zubiaur J, Jurado-Roman A, Fernandez-Portales J, et al
    Coronary Rotational Atherectomy Elective Versus Bailout in Patients With Severely Calcified Lesions and Chronic Renal Failure (CRATER) Trial.
    Catheter Cardiovasc Interv. 2025;106:1702-1712.
    PubMed         Abstract available
    
    
34. TAFCIU E, Pesarini G, Ribichini F
    Ultrasound Imaging Integration to Prevent Coronary Obstruction During Valve-In-Valve Transcatheter Aortic Valve Implantation.
    Catheter Cardiovasc Interv. 2025 Jul 1. doi: 10.1002/ccd.31740.
    PubMed         Abstract available
    
    
35. WU C, Zheng Y, Zhang T, Liu M, et al
    Incidence and Influencing Factors of In-Stent Restenosis After Percutaneous Coronary Intervention in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis.
    Catheter Cardiovasc Interv. 2025 Jul 1. doi: 10.1002/ccd.31711.
    PubMed         Abstract available
    
    
36. BACHA Z, Javed J, Khattak F, Qadri M, et al
    Transcatheter Versus Surgical Approach for the Treatment of Aortic Stenosis in Patients With Concomitant Coronary Artery Disease: A Systematic Review and Meta-Analysis.
    Catheter Cardiovasc Interv. 2025 Jul 1. doi: 10.1002/ccd.31697.
    PubMed         Abstract available
    
    
37. TOMASELLO SD, Rochira C, Mazzapicchi A, Legnazzi M, et al
    Clinical Outcomes of Percutaneous Coronary Intervention Using Excimer Laser Coronary Atherectomy for Complex Coronary Lesions: The ACCELERATE Registry.
    Catheter Cardiovasc Interv. 2025 Jun 30. doi: 10.1002/ccd.31739.
    PubMed         Abstract available
    
    
38. DUMITRU I, DeWolf J, Sevillano M, Schnell L, et al
    Utilization of Impella RP Flex for Right Ventricular Recovery in Cardiogenic Shock: A Single-Center Experience.
    Catheter Cardiovasc Interv. 2025;106:1593-1599.
    PubMed         Abstract available
    
    
39. SALEH H, Sharma D, Afify H, Sharma R, et al
    Outcomes Following Orbital Atherectomy for Coronary Calcified Nodules: A Retrospective Single-Center Experience.
    Catheter Cardiovasc Interv. 2025;106:1584-1590.
    PubMed         Abstract available
    
    
40. OKAMOTO A, Yamazaki T, Yamaguchi T, Fukuda D, et al
    Dual Device Fragment Retrieval Using Two-Wire and Snare Technique During Percutaneous Coronary Intervention: A Case of Guide Extension Tip and Balloon Shaft Separation.
    Catheter Cardiovasc Interv. 2025 Jun 26. doi: 10.1002/ccd.31721.
    PubMed         Abstract available
    
    
41. CARVALHO PEP, Cavalcante JL, Lesser J, Cheng V, et al
    Coronary Computed Tomography Angiography for Percutaneous Coronary Intervention: Initial United States Experience With FFR(CT) Based Virtual PCI.
    Catheter Cardiovasc Interv. 2025 Jun 26. doi: 10.1002/ccd.31720.
    PubMed         Abstract available
    
    

    
    Circ Cardiovasc Imaging

42. HOEK R, Somsen YBO, de Winter RW, Jukema RA, et al
    Diagnostic Value of Relative Flow Reserve in Patients With Prior Coronary Artery Disease: A Post Hoc Analysis of the PACIFIC-2 Trial.
    Circ Cardiovasc Imaging. 2025 Aug 30:e018574.
    PubMed         Abstract available
    
    

    
    Circ J

43. HARA T, Sata M
    Cancer-Associated Thrombosis, With a Focus on Ischemic Heart Disease.
    Circ J. 2025 Aug 29. doi: 10.1253/circj.CJ-25-0627.
    PubMed         Abstract available
    
    

    
    Circulation

44. HUDED CP, Spertus JA, Jones PG, O'Brien SM, et al
    Health Status Outcomes With Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting in ISCHEMIA.
    Circulation. 2025 Sep 5. doi: 10.1161/CIRCULATIONAHA.125.073591.
    PubMed         Abstract available
    
    
45. SHI F, Zheng B, Liu Y
    Letter by Shi et al Regarding Article "Associations of Circulating ANGPTL3, C-Terminal Domain-Containing ANGPTL4, and ANGPTL3/8 and ANGPTL4/8 Complexes with LPL Activity, Diabetes, Inflammation, and Cardiovascular Mortality".
    Circulation. 2025;152:e71-e72.
    PubMed        
    
    
46. NAMBI V, de Lemos JA, Ballantyne CM
    A Proposal to Elevate the Status of Troponin and B-Type Natriuretic Peptides as Atherosclerotic Cardiovascular Disease Risk Enhancers.
    Circulation. 2025;152:567-569.
    PubMed        
    
    
47. KUEHN BM
    Microplastics Exposure Linked to Cardiovascular Disease Risk, Chronic Health Conditions.
    Circulation. 2025;152:630-631.
    PubMed        
    
    
48. SILBERNAGEL G, Wen Y, Konrad RJ
    Response by Silbernagel et al to Letters Regarding Article, "Associations of Circulating ANGPTL3, C-Terminal Domain-Containing ANGPTL4, and ANGPTL3/8 and ANGPTL4/8 Complexes with LPL Activity, Diabetes, Inflammation, and Cardiovascular Mortality".
    Circulation. 2025;152:e73-e74.
    PubMed        
    
    
49. HUANG J
    Letter by Huang Regarding Article, "Associations of Circulating ANGPTL3, C-Terminal Domain-Containing ANGPTL4, and ANGPTL3/8 and ANGPTL4/8 Complexes with LPL Activity, Diabetes, Inflammation, and Cardiovascular Mortality".
    Circulation. 2025;152:e69-e70.
    PubMed        
    
    
50. CROON PM, Dhingra LS, Biswas D, Oikonomou EK, et al
    Phenotypic Selectivity of Artificial Intelligence-enhanced Electrocardiography in Cardiovascular Diagnosis and Risk Prediction.
    Circulation. 2025 Sep 1. doi: 10.1161/CIRCULATIONAHA.125.076279.
    PubMed         Abstract available
    
    

    
    Clin Cardiol

51. HAIDER NU, Rayyan SM, Abbas M
    Case Ascertainment and Exposure Classification in Acute Myocardial Infarction Mortality Studies Involving Psychoactive Substance Use.
    Clin Cardiol. 2025;48:e70202.
    PubMed        
    
    

    
    Clin Chem

52. SALONEN SM, Kristensen JH, Simonen S, Hasselbalch RB, et al
    Exploring the Role of Cardiac Troponin-Specific Autoantibodies: Prolonged Cardiac Troponin Elimination, Reduced Clearance, and Variable Interference across 5 Commercial Assays.
    Clin Chem. 2025;71:970-979.
    PubMed         Abstract available
    
    

    
    Eur Heart J

53. GIRAUD MN
    Macrophage leukotriene B4 production sustains inflammation after myocardial infarction.
    Eur Heart J. 2025 Sep 4:ehaf471. doi: 10.1093.
    PubMed        
    
    
54. CHEN Z, Song J, Feng S, Liu M, et al
    Arachidonic acid fuels inflammation by unlocking macrophage protein phosphatase 5 after myocardial infarction.
    Eur Heart J. 2025 Sep 4:ehaf493. doi: 10.1093.
    PubMed         Abstract available
    
    
55. AMICONE S, Fedele D, Pizzi C
    Revascularization in latecomer ST-elevation myocardial infarction patients: diverging ACC/AHA and ESC Guidelines.
    Eur Heart J. 2025 Sep 3:ehaf616. doi: 10.1093.
    PubMed        
    
    
56. ROSSELLO X, Dominguez-Rodriguez A, Latini R, Sanchez PL, et al
    Beta-blockers after myocardial infarction: effects according to sex in the REBOOT trial.
    Eur Heart J. 2025 Aug 30:ehaf673. doi: 10.1093.
    PubMed         Abstract available
    
    
57. GOULD KL, Johnson NP, Roby AE, Kirkeeide R, et al
    Optimal medical care and coronary flow capacity-guided myocardial revascularization vs usual care for chronic coronary artery disease: the CENTURY trial.
    Eur Heart J. 2025;46:3273-3286.
    PubMed         Abstract available
    
    

    
    Heart

58. D'ENTREMONT MA, Jolly SS, Alharthi F, Shah B, et al
    Benefit-risk of colchicine and spironolactone in acute myocardial infarction: a prespecified generalised pairwise comparisons analysis of the CLEAR trial.
    Heart. 2025 Sep 4:heartjnl-2025-326218. doi: 10.1136/heartjnl-2025-326218.
    PubMed         Abstract available
    
    

    
    Int J Cardiol

59. DILENA DD, Huang J, Rauchwerger AS, Reed ME, et al
    Identifying low-risk patients within the observation zone of a 0/2-h high-sensitivity troponin diagnostic protocol for chest pain evaluation.
    Int J Cardiol. 2025;440:133730.
    PubMed         Abstract available
    
    
60. LI S, Bo K, Ma W, Li W, et al
    Impact of metabolic dysfunction-associated fatty liver disease on left ventricular function and myocardial strain in patients with ASTEMI: Insights from a 3.0-T cardiac magnetic resonance study.
    Int J Cardiol. 2025;440:133709.
    PubMed         Abstract available
    
    
61. LIU C, Yang F, Hu Y, Wang L, et al
    Relationship between coronary artery calcification and plaque vulnerability, a qualitative and quantitative optical coherence tomography study.
    Int J Cardiol. 2025;440:133707.
    PubMed         Abstract available
    
    
62. KOCH T, Tauchmann L, Cassese S, Xhepa E, et al
    Long-term safety and efficacy of rotational atherectomy for lesion preparation of calcified coronary lesions.
    Int J Cardiol. 2025;440:133711.
    PubMed         Abstract available
    
    
63. RALLIDIS LS, Tsamoulis D, Papathanasiou KA, Kalogeras P, et al
    Eligibility for icosapent ethyl 1-3 months after acute coronary syndrome and the risk for myocardial re-infarction: Data from the CALLINICUS-Hellas Registry.
    Int J Cardiol. 2025;440:133684.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

64. JAIN SS, Mortazavi BJ, Chan You S, Yao X, et al
    Moving Beyond the Model: Our Perspective on Meaningful AI Research in Cardiovascular Care.
    J Am Coll Cardiol. 2025;86:691-695.
    PubMed        
    
    
65. INOUE S
    Reassessing Clonal Hematopoiesis as a Cardiovascular Risk Factor in Older Women: It's Not Just Age.
    J Am Coll Cardiol. 2025 Aug 19:S0735-1097(25)07497.
    PubMed        
    
    
66. RAY KK, Szarek M, Bhatt DL, Bittner VA, et al
    Lipoprotein(a) identifies patients with acute coronary syndromes who derive cardiovascular benefit from alirocumab, particularly for limb events.
    J Am Coll Cardiol. 2025 Aug 21:S0735-1097(25)07551.
    PubMed        
    
    
67. GALLI M, Benenati S, Laudani C, Simeone B, et al
    Cardiovascular Effects and Tolerability of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of 99,592 patients.
    J Am Coll Cardiol. 2025 Aug 19:S0735-1097(25)07492.
    PubMed         Abstract available
    
    
68. PICCOLO R, Calabro P, Carrara G, Simonetti F, et al
    Personalized or Standard Duration of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention: PARTHENOPE Randomized Trial.
    J Am Coll Cardiol. 2025 Aug 25:S0735-1097(25)07548.
    PubMed         Abstract available
    
    
69. OSTROMINSKI JW, Harrington J, Claggett BL, Filippatos G, et al
    Anthropometric Measures, Cardiovascular Outcomes, and Treatment Effects of Finerenone in Cardiovascular-Kidney-Metabolic Disease: Pooled Participant-Level Analysis of Three Global Trials.
    J Am Coll Cardiol. 2025 Aug 20:S0735-1097(25)07505.
    PubMed         Abstract available
    
    
70. NICHOLLS SJ, Nelson AJ, Ray KK, Ballantyne CM, et al
    Impact of Obicetrapib on Major Adverse Cardiovascular Events in High-Risk Patients: A Pooled Analysis.
    J Am Coll Cardiol. 2025 Aug 20:S0735-1097(25)07383.
    PubMed         Abstract available
    
    
71. KRUMHOLZ HM, Pagidipati NJ
    Obicetrapib and Cardiovascular Events: A Promising Signal in Need of Confirmation.
    J Am Coll Cardiol. 2025 Aug 21:S0735-1097(25)07430.
    PubMed        
    
    

    
    J Mol Cell Cardiol

72. JIANG Y, Estau D, Qiao Y, Li Z, et al
    14-3-3/HIP-55 complex attenuates cardiomyocyte apoptosis.
    J Mol Cell Cardiol. 2025;206:91-101.
    PubMed         Abstract available
    
    

    
    J Thorac Cardiovasc Surg

73. KIM MS, Ryu AJ, Kim JW, Lee CH, et al
    Prediction of graft patency during the year following coronary artery bypass grafting: preoperative computed tomography-derived fractional flow reserve versus intraoperative transit-time flow measurement.
    J Thorac Cardiovasc Surg. 2025 Aug 30:S0022-5223(25)00684.
    PubMed         Abstract available
    
    

    
    JAMA

74. PUSTJENS TFS, Veenstra L, Camaro C, Ruiters AW, et al
    Fractional Flow Reserve-Guided Complete vs Culprit-Only Revascularization in Non-ST-Elevation Myocardial Infarction and Multivessel Disease: The SLIM Randomized Clinical Trial.
    JAMA. 2025 Aug 31:e2516189. doi: 10.1001/jama.2025.16189.
    PubMed         Abstract available
    
    
75. HOFMANN R, James S, Sundqvist MO, Warme J, et al
    Helicobacter pylori Screening After Acute Myocardial Infarction: The Cluster Randomized Crossover HELP-MI SWEDEHEART Trial.
    JAMA. 2025 Sep 1:e2515047. doi: 10.1001/jama.2025.15047.
    PubMed         Abstract available
    
    
76. LASSEN MCH, Johansen ND, Christensen SH, Aliabadi N, et al
    Bivalent RSV Prefusion F Protein-Based Vaccine for Preventing Cardiovascular Hospitalizations in Older Adults: A Prespecified Analysis of the DAN-RSV Trial.
    JAMA. 2025 Aug 30:e2515405. doi: 10.1001/jama.2025.15405.
    PubMed         Abstract available
    
    
77. CHU HY, Murray AF
    Shot Through the Heart-Can RSV Vaccination Reduce Risk of Cardiovascular Outcomes?
    JAMA. 2025 Aug 30. doi: 10.1001/jama.2025.16705.
    PubMed        
    
    

    
    Lancet

78. KIM MC, Ahn JH, Hyun DY, Lim Y, et al
    Immediate versus staged complete revascularisation during index admission in patients with ST-segment elevation myocardial infarction and multivessel disease (OPTION-STEMI): a multicentre, non-inferiority, open-label, randomised trial.
    Lancet. 2025 Aug 28:S0140-6736(25)01529-6. doi: 10.1016/S0140-6736(25)01529.
    PubMed         Abstract available
    
    
79. BYRNE RA, Coughlan JJ
    Immediate or staged complete revascularisation in patients with ST segment elevation myocardial infarction.
    Lancet. 2025 Aug 28:S0140-6736(25)01680-0. doi: 10.1016/S0140-6736(25)01680.
    PubMed        
    
    
80. ROSSELLO X, Prescott EIB, Kristensen AMD, Latini R, et al
    beta blockers after myocardial infarction with mildly reduced ejection fraction: an individual patient data meta-analysis of randomised controlled trials.
    Lancet. 2025 Aug 29:S0140-6736(25)01592-2. doi: 10.1016/S0140-6736(25)01592.
    PubMed         Abstract available
    
    
81. UDELL JA, Bahit MC, Campbell P, Butler J, et al
    Prevention of heart failure after acute myocardial infarction.
    Lancet. 2025 Aug 28:S0140-6736(25)01394-7. doi: 10.1016/S0140-6736(25)01394.
    PubMed         Abstract available
    
    
82. VERMA S, Leiter LA, Teoh H, Mancini GBJ, et al
    Effect of evolocumab on saphenous vein graft patency after coronary artery bypass surgery (NEWTON-CABG CardioLink-5): an international, randomised, double-blind, placebo-controlled trial.
    Lancet. 2025 Aug 28:S0140-6736(25)01633-2. doi: 10.1016/S0140-6736(25)01633.
    PubMed         Abstract available
    
    
83. GAUDINO M, Sandner S
    Evolocumab for prevention of coronary artery bypass failure: timing is everything.
    Lancet. 2025 Aug 28:S0140-6736(25)01718-0. doi: 10.1016/S0140-6736(25)01718.
    PubMed        
    
    
84. GUO X, Sun G, Xu Y, Zhou S, et al
    Benefit-harm trade-offs of intensive blood pressure control versus standard blood pressure control on cardiovascular and renal outcomes: an individual participant data analysis of randomised controlled trials.
    Lancet. 2025 Aug 28:S0140-6736(25)01391-1. doi: 10.1016/S0140-6736(25)01391.
    PubMed         Abstract available
    
    
85. VALGIMIGLI M, Choi KH, Giacoppo D, Gragnano F, et al
    Clopidogrel versus aspirin for secondary prevention of coronary artery disease: a systematic review and individual patient data meta-analysis.
    Lancet. 2025 Aug 28:S0140-6736(25)01562-4. doi: 10.1016/S0140-6736(25)01562.
    PubMed         Abstract available
    
    
86. OSTROMINSKI JW, Cheng AYY, Nelson AJ, Neuen BL, et al
    Cardiovascular, kidney, and metabolic health: an actionable vision for heart failure prevention.
    Lancet. 2025 Aug 28:S0140-6736(25)01384-4. doi: 10.1016/S0140-6736(25)01384.
    PubMed         Abstract available
    
    

    
    N Engl J Med

87. TARANTINI G, Honton B, Paradies V, Lemesle G, et al
    Early Discontinuation of Aspirin after PCI in Low-Risk Acute Myocardial Infarction.
    N Engl J Med. 2025 Aug 31. doi: 10.1056/NEJMoa2508808.
    PubMed         Abstract available
    
    
88. MUNKHAUGEN J, Kristensen AMD, Halvorsen S, Holmager T, et al
    Beta-Blockers after Myocardial Infarction in Patients without Heart Failure.
    N Engl J Med. 2025 Aug 30. doi: 10.1056/NEJMoa2505985.
    PubMed         Abstract available
    
    
89. IBANEZ B, Latini R, Rossello X, Dominguez-Rodriguez A, et al
    Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction.
    N Engl J Med. 2025 Aug 30. doi: 10.1056/NEJMoa2504735.
    PubMed         Abstract available
    
    
90. NICHOLLS SJ, Nelson AJ, Ray KK
    Safety and Efficacy of Obicetrapib in Patients at High Cardiovascular Risk. Reply.
    N Engl J Med. 2025;393:928.
    PubMed        
    
    
91. GUO M, Liu Z
    Safety and Efficacy of Obicetrapib in Patients at High Cardiovascular Risk.
    N Engl J Med. 2025;393:927-928.
    PubMed        
    
    
92. ZHANG D, Wu H, Gong S
    Safety and Efficacy of Obicetrapib in Patients at High Cardiovascular Risk.
    N Engl J Med. 2025;393:927.
    PubMed        
    
    
93. MODARRESSI T
    Safety and Efficacy of Obicetrapib in Patients at High Cardiovascular Risk.
    N Engl J Med. 2025;393:926-927.
    PubMed        
    
    
94. JEPPSSON A, James S, Moller CH, Malm CJ, et al
    Ticagrelor and Aspirin or Aspirin Alone after Coronary Surgery for Acute Coronary Syndrome.
    N Engl J Med. 2025 Sep 1. doi: 10.1056/NEJMoa2508026.
    PubMed         Abstract available
    
    
95. LEMESLE G, Didier R, Steg PG, Simon T, et al
    Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation.
    N Engl J Med. 2025 Aug 31. doi: 10.1056/NEJMoa2507532.
    PubMed         Abstract available
    
    
96. GUIMARAES PO, Franken M, Tavares CAM, Antunes MO, et al
    Early Withdrawal of Aspirin after PCI in Acute Coronary Syndromes.
    N Engl J Med. 2025 Aug 31. doi: 10.1056/NEJMoa2507980.
    PubMed         Abstract available
    
    

    
    PLoS One

97. ULLAH H, Huma S, Ashraf M, Tahir N, et al
    Relationship of vitamin D, fibrinogen and their ratio with acute coronary syndrome: A comparative analysis of unstable angina, NSTEMI, and STEMI.
    PLoS One. 2025;20:e0331853.
    PubMed         Abstract available
    
    
98. RANJAN R, Momin A, Kaba RA, Ken-Dror G, et al
    Safety and resource utilisation efficiency of semi-skeletonised versus skeletonised left internal mammary artery harvesting techniques: The BANGABANDHU study.
    PLoS One. 2025;20:e0331285.
    PubMed         Abstract available
    
    
99. ALSALEH A, AlSaif SM, Alhadramy O, Alshehri M, et al
    The second survey of the Saudi Acute Myocardial Infarction Registry Program: Main results and temporal changes in care (STARS-2 program).
    PLoS One. 2025;20:e0331215.
    PubMed         Abstract available
    
    
100. LV Y, Wei L, Wang Z, Mu Z, et al
     Association between hemoglobin glycation index and 28-day all-cause mortality in acute myocardial infarction patients: Analysis of the MIMIC-IV database.
     PLoS One. 2025;20:e0330819.
     PubMed         Abstract available
     
     

     
     Prog Cardiovasc Dis

101. JAISWAL V, Hanif M, Kumar D, Mashkoor Y, et al
     Comparative effectiveness of sodium-glucose cotransporter 2 inhibitors along with colchicine versus colchicine alone among coronary artery disease and type 2 diabetes patients.
     Prog Cardiovasc Dis. 2025 Sep 2:S0033-0620(25)00132.
     PubMed         Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.